St. Louis Practice Updates Dysport and Xeomin Treatment Planning

Saint Louis, United States – May 21, 2026 / Modern Med Aesthetics & Wellness /

SAINT LOUIS, MO, May 20, 2026 — Modern Med Aesthetics & Wellness announced the introduction of updated neuromodulator assessment workflows for Dysport and Xeomin patients, adding structured facial evaluation protocols and product selection processes for injectable wrinkle treatment planning.

According to the practice, demand for neuromodulator services has continued to grow as patients seek more structured guidance around injectable options, treatment-area planning, dosing considerations, and maintenance timelines. The update reflects increased interest in process-driven aesthetic care that accounts for facial anatomy, muscle movement patterns, and treatment history before injection appointments are scheduled.

“Patients often come in with questions about the differences between Dysport and Xeomin, and our updated workflow gives our team a more consistent framework for evaluating those options,” said Lauren Pohle, NP-C, Owner of Modern Med Aesthetics & Wellness. “The goal is to support clear assessment, appropriate product selection, and coordinated treatment planning across each visit.”

The updated workflow begins with a facial assessment that reviews muscle activity, treatment goals, prior injectable use, and targeted areas such as forehead lines, frown lines, crow’s feet, chin dimpling, neck bands, and other advanced injection areas. This intake process is designed to support consistent documentation and individualized planning before treatment begins.

Modern Med Aesthetics & Wellness also incorporated product-specific review protocols for Dysport and Xeomin. These protocols account for differences in formulation, diffusion patterns, onset timing, treatment-area size, and precision requirements when determining how each neuromodulator may fit within a patient’s care plan.

The practice stated that Dysport may be considered in treatment plans involving larger facial areas where broader diffusion is appropriate, while Xeomin may be selected in cases requiring more targeted placement or when formulation considerations are part of the assessment process. Product selection remains dependent on provider evaluation, facial anatomy, and treatment-area requirements.

Additional operational updates include treatment-area mapping, unit estimation, appointment timing review, and post-treatment monitoring guidance. The workflow also supports recurring evaluation intervals for patients who maintain neuromodulator treatments over time.

Modern Med Aesthetics & Wellness reported that common patient concerns include dynamic wrinkles, repeated facial movement patterns, treatment longevity, product differences, and the desire for consistent planning across injectable appointments. These patterns contributed to the practice’s decision to formalize its Dysport and Xeomin consultation process.

The practice indicated that it will continue refining its injectable treatment workflows as patient demand evolves, product education expands, and aesthetic medicine protocols continue shifting toward structured assessment and coordinated treatment planning.

Media Contact

Modern Med Aesthetics & Wellness
Phone: (314) 394-0204
Email: modernmedstl@gmail.com
Website: Modern Med Aesthetics & Wellness

About Modern Med Aesthetics & Wellness

Modern Med Aesthetics & Wellness is a Saint Louis, Missouri-based aesthetic and wellness practice offering injectable treatments, skincare services, laser treatments, and wellness-focused services. Founded by Lauren Pohle, NP-C, the practice focuses on structured assessment protocols, coordinated treatment planning, and provider-led aesthetic care workflows.